Clinical Trial Update: Neural and Antidepressant Effects of Propofol (Phase 2) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial examining neural and antidepressant effects of propofol for treatment resistant depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: University of Utah | Conditions: Treatment Resistant Depression | Phase 2, Phase 3 | Status: WITHDRAWN